Executive Summary
The United States Court of Appeals for the Federal Circuit occupies a unique position within the federal judiciary. Unlike the regional courts of appeals, it exercises nationwide appellate jurisdiction over patent cases, appeals from the Patent Trial and Appeal Board, many appeals from the International Trade Commission, the Court of Federal Claims, veterans’ matters, and other specialized areas of federal law. Consequently, changes in the composition of the court can have long-lasting effects on innovation, intellectual property enforcement, and regulated industries, including the pharmaceutical and biotechnology sectors.
The Federal Circuit’s Unique Role
Created by Congress in 1982, the Federal Circuit was intended to promote uniformity in patent jurisprudence by consolidating patent appeals within a single appellate court. Its decisions influence research-intensive industries, generic and innovator pharmaceutical companies, medical device manufacturers, universities, technology companies, and investors whose commercial expectations often depend upon predictable patent law.
Article III Judges and Life Tenure
Judges of the Federal Circuit are Article III judges appointed by the President with the advice and consent of the Senate. Once commissioned, they hold office during good behavior and are not subject to mandatory retirement. An Article III judge may remain in active service indefinitely unless the judge resigns, retires, assumes senior status, or is removed through impeachment.
Senior Status Versus Retirement
Senior status should not be confused with retirement. A judge assuming senior status remains an Article III judge, may continue hearing cases, and frequently maintains a substantial judicial workload. Most importantly, when an active judge elects senior status, the active judgeship becomes vacant, allowing the President to nominate a successor. Thus, elections to senior status often create opportunities to reshape the future composition of the court.
The Rule of 80 for Senior Status
Eligibility for senior status is governed principally by 28 U.S.C. §371(c), commonly referred to as the “Rule of 80.” The statute balances a judge’s age with years of Article III judicial service. Beginning at age sixty-five, fewer years of service are required as the judge becomes older.
| Age |
Minimum Article III Service |
| 65 |
15 years |
| 66 |
14 years |
| 67 |
13 years |
| 68 |
12 years |
| 69 |
11 years |
| 70 |
10 years |
Service on another Article III court, such as a United States District Court, counts toward these service requirements. Accordingly, judges elevated from a district court may become eligible for senior status earlier than judges whose first Article III appointment is to the Federal Circuit.
Why Eligibility Does Not Predict Vacancies
Although the Rule of 80 establishes when a judge first becomes eligible for senior status, it does not require the judge to step aside. Several Federal Circuit judges have remained in active service for many years after first becoming eligible. Consequently, eligibility dates should be viewed as identifying potential, not certain, future opportunities for a presidential appointment.
Eligibility Does Not Equal Retirement
Rule-of-80 eligibility establishes only the earliest date on which a judge may elect senior status. Numerous Federal Circuit judges have remained active for years after becoming eligible. Personal considerations, health, professional interests, workload, and institutional factors all influence whether and when a judge assumes senior status.
Why This Matters to Clients
For companies whose businesses depend upon patents, regulatory exclusivities, government contracts, or specialized federal litigation, the composition of the Federal Circuit matters. Changes in membership may influence the development of precedent affecting patent eligibility, claim construction, obviousness, damages, injunctions, PTAB review, Hatch-Waxman litigation, and other recurring issues. While judges are bound to decide cases according to law rather than policy preferences, every new appointment contributes to the court’s institutional experience and jurisprudence.
The Current Federal Circuit: Composition, Eligibility, and Institutional Observations
This section examines the current composition of the United States Court of Appeals for the Federal Circuit. Understanding the backgrounds of the active judges provides context for future vacancies and illustrates why eligibility for senior status should not be confused with an expectation of retirement.
Current Active Judges
Judges are listed in order of seniority, that is, by date of commission. Shaded rows indicate judges who are already eligible to elect senior status.
| Judge |
Commissioned |
Age at Commission |
Appointed By |
Senior-Status Eligible |
| Moore |
Sept. 8, 2006 |
38 |
GW Bush |
June 15, 2033 |
| Newman |
Feb. 28, 1984 |
56 |
Reagan |
1999 |
| Lourie |
Apr. 6, 1990 |
55 |
HW Bush |
2000 |
| Dyk |
May 25, 2000 |
63 |
Clinton |
2010 |
| Prost |
Sept. 24, 2001 |
50 |
GW Bush |
2021 |
| Reyna |
Apr. 5, 2011 |
58 |
Obama |
2022 |
| Taranto |
Mar. 12, 2013 |
55 |
Obama |
May 6, 2027 |
| Chen |
Aug. 2, 2013 |
44/45 |
Obama |
Sept. 22, 2033 |
| Hughes |
Sept. 24, 2013 |
47 |
Obama |
Nov. 1, 2031 |
| Stoll |
July 8, 2015 |
46 |
Obama |
Nov. 1, 2033 |
| Cunningham |
Aug. 6, 2021 |
45 |
Biden |
May 27, 2041 |
| Stark* |
Mar. 16, 2022 |
52 |
Biden |
July 5, 2034 |
* Judge Stark previously served as a United States District Judge for the District of Delaware, commissioned August 10, 2010. That prior Article III service counts toward his Rule-of-80 calculation. No other active judge previously served on another Article III court.
Observations from the Current Court
Several themes emerge from the present composition of the court. First, appointment ages vary widely, from the late thirties to the early sixties. Younger appointees generally accumulate substantially more years of judicial service before becoming eligible for senior status, while judges appointed later in life may become eligible after fewer years because the Rule of 80 balances age and service.
Second, five active judges have already been eligible for senior status for years. Their continued active service demonstrates that Rule-of-80 eligibility identifies only the first date on which a judge may elect senior status; it does not predict whether, or when, a vacancy will actually occur.
Third, prior Article III service is significant. Judge Leonard P. Stark served as a United States District Judge before joining the Federal Circuit. Because service on another Article III court counts toward the statutory calculation, judges elevated from the district court bench reach senior-status eligibility sooner than first-time Article III appointees with the same age.
The Chief Judge Requirements
Under the Chief Judge statute, Chief Judge Moore’s 7-year term will end on May 22, 2028. Chief Judges serve for 7-year terms or until age 70, whichever comes first. Accordingly, in May 2028 Chief Judge Moore’s 7-year term will end even though she will be only 59. The next Chief Judge will be Judge Chen because Judges Newman, Dyk, Prost, Reyna, and Taranto will not be eligible. Each of them will age out (the statute limits the Chief position to age 65 or less when the vacancy happens). Judge Chen was commissioned about 7 weeks before Judge Hughes and thus has 7 weeks of seniority.
Why the Court Matters to Patent Owners
For patent owners, Federal Circuit precedent often determines the practical value of a patent portfolio. Decisions addressing patent eligibility, claim construction, obviousness, written description, enablement, infringement, damages, injunctions, and equitable defenses affect licensing negotiations, investment decisions, research and development strategies, and litigation risk.
Why the Court Matters to Patent Challengers
Companies defending infringement claims likewise rely upon predictable Federal Circuit jurisprudence. Generic pharmaceutical companies, technology companies, manufacturers, and other accused infringers frequently challenge patent validity or contest infringement. The Federal Circuit’s interpretation of the Patent Act, review of Patent Trial and Appeal Board decisions, and standards governing summary judgment, expert testimony, and appellate review directly influence litigation strategy.
The Importance to the Pharmaceutical Industry
The pharmaceutical industry is particularly affected because many appeals arise under the Hatch-Waxman Act. Federal Circuit decisions influence Orange Book litigation, patent-term issues, obviousness, written description, induced infringement, ANDA litigation, biosimilar disputes, and remedies. For both innovator and generic companies, consistent appellate guidance promotes greater predictability in product development and commercialization. There is a perception, whether correct or incorrect, that certain Judges are pro-patentee and thus anti-generic drug company; and vice versa.
The Value of Diverse Professional Backgrounds
The current and historical membership of the Federal Circuit demonstrates that judges arrive with a wide range of professional experience. Some previously served as district judges, others practiced extensively in private law firms, while others held senior government positions or worked within the U.S. Patent and Trademark Office or the Department of Justice. This diversity of experience might enrich the court’s institutional perspective without diminishing the obligation of every judge to apply the law impartially.
Prior private-practice experience may provide familiarity with the practical realities of patent litigation, client counseling, licensing, technology transactions, and business decision-making. Prior judicial experience may contribute insights regarding trial management, evidentiary rulings, and standards of appellate review. Government service may bring substantial experience with administrative law, agency decision-making, and federal litigation. None of these backgrounds dictates judicial outcomes; rather, they contribute to the breadth of experience represented on the court.
Why Businesses Monitor Federal Circuit Vacancies
Although no single judicial appointment is expected to alter established precedent immediately, changes in court membership are closely followed because they gradually shape the court’s institutional character. Companies with significant intellectual property assets, ongoing research programs, or recurring Federal Circuit litigation often monitor vacancies and confirmations as part of their broader legal risk assessment.
Those businesses or associations will often lobby the President to appoint so called “pro-patent,” “pro-competition,” or “anti-patent” judges to the Court, depending on what side of the “v.” that party is on. But for the Court’s purpose, that is too narrow. Because the Court has a diverse subject matter scope, a focus on patent law experience deprives the court of experience in other subjects.
Practical Takeaways for Clients
Clients should recognize three practical points. First, senior-status eligibility does not necessarily indicate an impending vacancy. Second, each appointment contributes additional experience and perspective to a court that exercises nationwide jurisdiction over patent law. Third, because Federal Circuit precedent affects innovation across numerous industries, developments concerning the court deserve attention from in-house counsel, patent professionals, and business leaders alike.
Conclusion
Understanding the Rule of 80 and the current composition of the Federal Circuit provides useful context for clients whose businesses depend on stable and predictable patent jurisprudence. While no eligibility date guarantees a vacancy, informed monitoring of the court’s composition remains valuable for companies engaged in intellectual property and other specialized federal litigation.
How can we help you?
We can help “clear the way” of potential IP rights. We also help enforce patents against competitors. We help clients in patent litigation, appeals, counseling, opinions of counsel, and PTAB proceedings. When your current firm needs help or the client needs a change of counsel, we can help. For investors, we provide the deep dive due diligence to find any problems in the patent portfolio or vet out the accuracy of pitch-decks.
About Upadhye Tang LLP
Upadhye Tang LLP is an IP and FDA boutique firm concentrating on the pharmaceutical, life sciences, and medical device spaces. We help clients with navigating the legal landscape by helping on counseling and litigation. Clients call us to help move drug and device approvals along and to represent them in IP and commercial litigation. Call Chris Bruno, 312-598-2613 or by email
chris@ipfdalaw.com for more information.
No Attorney-Client Relationship or Legal Advice
The content of this website has been prepared by Upadhye Tang LLP for informational purposes only and does not constitute legal advice. Nothing shall not be construed as an offer to represent you, nor is it intended to create, nor shall the receipt of such information constitute, an attorney-client relationship. Please call us first with any questions about the firm.
Nobody should take any action or choose not to take any action based upon the information on this website without first seeking appropriate professional counsel from an attorney licensed in the user’s jurisdiction. Because the content of any unsolicited Internet email sent to Upadhye Tang LLP at any of the email addresses set forth in this website will not create an attorney-client relationship and will not be treated as confidential, you should not send us information until you speak to one of our lawyers and get authorization to send that information to us.
Individual Opinions
The opinions and views expressed on or through this website, or any newsletter, are the opinions of the designated authors only, and do not reflect the opinions or views of any of their clients or law firms or the opinions or views of any other individual. And nothing said in any newsletter or website reflects any binding admission or authority.
